Navigation Links
A Synthetic Molecule Instigates Cancer Cells To Self-Harm

Scientists have devised a method to outwit cancer cells and instigate them to self-harm, ultimately causing death of cancer cells. This novel discovery could unlock reliable// treatments for cancer.

This discovery works on the known principle that involves the activation of the body’s many defenses, to check the abnormal growth of cells; the way to achieve this is to get the faulty cells to kill themselves. This natural process, termed as apoptosis, involves he role of a protein called procaspase-3. When triggered, procaspase-3 changes into an enzyme called caspase-3, that causes the cells to die.

During cancer, this mechanism in the body is rendered defective, which is why the abnormal growth of cells carries on unchecked. Often the cancers are pretty strong to combat the natural defense forces in the body, and are stronger than the chemotherapy drugs.

But Paul Hergenrother, a chemist at the University of Illinois at Urbana-Champaign, has discovered a method to get the natural biological process, to go on unimpeded, which is to have a synthetic molecule that actually triggers apoptosis. For this, the team scrutinized 20,000 different compounds that portrayed the abilities to change procaspase-3 into caspase-3. This potent molecule was termed as PAC -1

PAC-1 was found to be able to obliterate many types of cancer cells, but its efficacy was based upon the levels of procaspase-3 in the body.

Quoting the words of Prof Hergenrother, "As such, the potential effectiveness of a compound such as PAC-1 could be assessed ... with a high degree of accuracy, and people with cancer could be pre-selected for treatment with a procaspase-3 activator based on the concentration of procaspase-3 in their tumor cells."
'"/>




Page: 1

Related medicine news :

1. New Study Will The Look Into The Effects Of Synthetic Steroids
2. Synthetic protein found to relieve arthritis symptoms in animal model
3. Synthetic Bone Tissue Could Be the Answer to Disfigurement Caused by Oral Cancer
4. Synthetic DNA Makes Better Hydrogels for Drug Delivery
5. Super Chow, Laced With Semi-Synthetic Vitamin E, Inhibited Spread of Cancer
6. Synthetic Chemicals May Trigger Breast Cancer
7. Synthetic Cannabinoid Could Improve Fertility in Smokers
8. Chemicals Used To Make Synthetic Color Can Cause Cancer And Permanent Blindness
9. New Molecule that can stop the growth of Viruses
10. Puberty may be due to GPR54 gene and KiSS-1 Molecule
11. Molecule responsible for muscle repair identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/13/2017)... ATLANTA , Sept. 13, 2017   OrthoAtlanta ... to the Atlanta Football Host Committee (AFHC) for the 2018 ... Monday, Jan. 8, 2018, at Mercedes-Benz Stadium in ... part of the AFHC "I,m In" campaign, participating in many ... ...
Breaking Medicine Technology: